pharmaceutical investing Antibe Therapeutics Announces Successful Completion of Part One of Phase 2B Dose-Ranging, Efficacy Study for ATB-346
pharmaceutical investing Antibe Therapeutics Receives Approval to Initiate Part Two of Phase 2B Dose-Ranging, Efficacy Study for ATB-346
1911 GOLD CLOSES C$23 MILLION "BEST EFFORTS" LIFE OFFERING & PRIVATE PLACEMENT AND PROVIDES CORPORATE UPDATES
Sranan Gold Continues to Extend the Mineralized Zone at the Randy's Pit Target, Tapanahony Project, Suriname
Western Copper and Gold Partners with Little Salmon Carmacks First Nation to Support School and Daycare Meal Programs
